|

Pentoxifylline Clinical Trials

4 actively recruiting trials across 1 location

▲ +1 trial since June 2026

Pipeline

Phase 2: 3

Top Sponsors

  • University of Sao Paulo General Hospital1
  • University Health Network, Toronto1
  • Tanta University1
  • M.D. Anderson Cancer Center1

Indications

  • Cancer2
  • Radiation Induced Lung Injury (RILI)1
  • Eisenmenger Syndrome1
  • Fibrosis Syndrome1
  • Heart Disease1

Other3 trials

Pentoxifylline as Anti-Inflammatory in Patients With Rheumatoid Arthritis
Phase 2
Pentoxifylline as an Adjunct Therapy for Patients With Eisenmenger Syndrome
N/A
Pneumonitis Prevention Protocol Using Pentoxifylline and α-tocopherol In Stage III Non-Small Cell Lung Cancer Patients Undergoing Chemoradiation
Phase 2

Houston, Texas1 trial

Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose)

MD Anderson Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.